Teens 5 Times More Likely to Develop Heart Conditions After mRNA COVID Injections
/From [HERE] Teenagers were up to five times more likely to develop myocarditis and pericarditis, and up to 10 times more likely to experience an anaphylactic reaction shortly after receiving an initial two-dose series of the mRNA COVID-19 vaccines, according to a new peer-reviewed study.
The study, published last week in Scientific Reports, also found an increased risk of appendicitis, epilepsy and convulsions, and lymphadenopathy — or swollen lymph nodes — in teens who received two doses of the Pfizer or Moderna COVID-19 shots.
The study was conducted by 13 Norwegian researchers using data from the Norwegian Patient Registry and the Norwegian Cause of Death Registry.
The researchers examined the data for 496,432 teenagers ages 12-19 in Norway — both vaccinated and unvaccinated — to analyze the short- and mid-term safety of the mRNA COVID-19 vaccines among teenagers.
Key findings included:
A fivefold higher rate of myocarditis and pericarditis among teenagers following the second dose (adjusted incidence rate ratio of 5.27) compared to unvaccinated teens.
A 37-fold higher rate of myocarditis and pericarditis among 12- to 15-year-olds who received the two-dose series, albeit among a small number of cases.
An approximately tenfold higher rate of anaphylactic reactions after the second dose, though based on a small number of cases.
A 65% higher risk of epilepsy and convulsions in infection-free teenagers who received the two-dose series.
A 47% higher risk of acute appendicitis nearly two months (56 days) after completing the two-dose COVID-19 vaccine series.
